The Hesperos team recently gathered for a private screening of the upcoming feature documentary, The New Gold Standard: Cutting Edge Science That’s Replacing Animal Testing. As pioneers in human-on-a-chip technology, our routine focus centers on the … Read More
Join Hesperos at the 2026 MPS World Summit in Washington, DC If you are attending the MPS World Summit (Washington, DC, 26 – 29 May 2026), please stop by Booth 523 to learn more about how … Read More
Hesperos and UCF publish new study in Alzheimer’s and Dementia demonstrating peripheral neuromuscular pathology is NOT CNS dependent in Alzheimer’s Disease
Details: Date: 08 April 2026 Time: 16:10 (UTC+2) Session 4: Integrating Micro-Physiological and Organ-on-Chip Systems with QSP Hesperos, Inc. is proud to announce that our Chief Scientist, Dr. James J. Hickman, will be a featured speaker … Read More
A 4-organHuman-on-a-Chip® model was used to study the safety profile of tradipitant, the results supported its recent approval for motion sickness.
Featured on the cover of Advanced Science, our study presents a human-derived Malaria-on-a-Chip system that captures the biology of infection and delivers actionable insights for real-world therapeutic translation.
Hesperos and AsedaSciences announce a strategic channel sales partnership combining Human-on-a-Chip® and AI-driven 3RnD® to advance safer, more efficient drug and chemical development.
Hesperos and Oriental Yeast Co. form a strategic partnership to expand access to Human-on-a-Chip® services across Asia, accelerating safer, more effective preclinical drug development.
Hesperos and GalenusRx receive $3M NIH grant to study drug-induced dementia using Human-on-a-Chip® systems and improve medication safety for older adults.
“[This] is a demonstration of how these novel technologies can be leveraged to develop a new treatment paradigm – moving away from the one-treatment-fits-all perspective and towards the development of personalized medicines,” Mihael H. Polymeropoulos, M.D., … Read More